Trial intelligence / Profile preview

[18F]MNI-1054 PET in Healthy Subjects

NCT03695926Phase 1Completed

Sponsor
Invicro
Start
Aug 2018
Primary completion
May 2019
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Invicro. Primary endpoints: Average and standard deviation across subjects of the variability ((test - retest) / average(test, retest)) at 1 year and Intraclass correlation at 1 year. Started Aug 2018; status: completed.

Beyond the preview

Go deeper on NCT03695926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03695926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call